Amneal Pharmaceuticals, Inc. (FRA:2DT)
Germany · Delayed Price · Currency is EUR 10.40
+0.40 (4.00%)
At close: Dec 19, 2025
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of €3.37 billion as of December 19, 2025. Its market cap has increased by 30.09% in one year.
Market Cap
3.37B
Enterprise Value
5.55B
Revenue
2.50B
Ranking
n/a
PE Ratio
670.62
Stock Price
€10.40
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from 1.60B to 3.37B, an increase of 110.86%. That is a compound annual growth rate of 10.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 3.37B | 42.27% |
| Dec 31, 2024 | 2.37B | 40.80% |
| Dec 29, 2023 | 1.68B | 496.83% |
| Dec 30, 2022 | 282.05M | -55.17% |
| Dec 31, 2021 | 629.13M | 14.07% |
| Dec 31, 2020 | 551.54M | -4.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |